These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5284372)

  • 21. Uterine perforation by intra-uterine contraceptive devices and their laparoscopic removal.
    Zuhair A; Buckle AE
    Int J Gynaecol Obstet; 1975; 13(3):101-4. PubMed ID: 6348
    [No Abstract]   [Full Text] [Related]  

  • 22. Menstrual blood-loss with intrauterine devices.
    Guillebaud J; Bonnar J; Morehead J; Matthews A
    Lancet; 1976 Feb; 1(7956):387-90. PubMed ID: 55650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of complications caused by intrauterine devices].
    Fabiani G; Pittino M; D'Aietti V; Dalla Pria S; Zaccagna G
    Minerva Ginecol; 1987 Sep; 39(9):639-42. PubMed ID: 3683970
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors.
    Anderson AB; Haynes PJ; Guillebaud J; Turnbull AC
    Lancet; 1976 Apr; 1(7963):774-6. PubMed ID: 56590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in menstrual bleeding caused by the use of the IUD].
    Pedrón Nuevo N
    Arch Invest Med (Mex); 1988; 19(3):245-52. PubMed ID: 3242436
    [No Abstract]   [Full Text] [Related]  

  • 26. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrinolytic control of menorrhagia after I.U.D. insertion.
    MacMath IF
    Practitioner; 1973 Mar; 210(257):417-20. PubMed ID: 4571360
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between endometrial mast cell count and bleeding in women following insertion of an intrauterine device.
    Mehra U; Devi PK; Chakravarti RN; Chaudhury RR
    Am J Obstet Gynecol; 1970 Jul; 107(6):852-6. PubMed ID: 4193675
    [No Abstract]   [Full Text] [Related]  

  • 30. Lochia and menstrual patterns in women with postpartum IUCD insertions.
    Hingorani V; Bai U; Kakkar AN
    Am J Obstet Gynecol; 1970 Nov; 108(6):989-90. PubMed ID: 5496057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
    Khanna A; Biswas AK; Dubey B; Khanna AK
    Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
    Weström L; Bengtsson LP
    J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins].
    Zhang JY; Luo LL
    Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):167-8, 190. PubMed ID: 1395902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminocaproic acid and menstrual loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Alleviation of IUD menorrhagia with ethamsylate.
    Harrison RF; Campbell S
    Br Med J; 1976 Mar; 1(6010):649-50. PubMed ID: 766907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
    Dasgupta PR; Dutta S; Banerjee P; Majumdar S
    Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications associated with the unsuspected presence of intrauterine contraceptive devices.
    Porges RF
    Am J Obstet Gynecol; 1973 Jun; 116(4):579-80. PubMed ID: 4709493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonorrhoea and the intrauterine contraceptive device.
    Statham R; Morton RS
    Br Med J; 1968 Dec; 4(5631):623-5. PubMed ID: 4972751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased endometrial fibrinolytic activity as a cause of menometrorrhagia in women using IUD's.
    Surico N; Tavassoli K; Porcelli A; Ferraris G
    Panminerva Med; 1988; 30(3):184-7. PubMed ID: 3211578
    [No Abstract]   [Full Text] [Related]  

  • 40. Uterine leiomyomata--aetiology, symptomatology and management.
    Buttram VC
    Prog Clin Biol Res; 1986; 225():275-96. PubMed ID: 3538059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.